Cargando…
Early Discontinuation of P2Y(12) Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
BACKGROUND: Early discontinuation of P2Y(12) antagonists post–percutaneous coronary intervention may increase risk of stent thrombosis or nonstent recurrent myocardial infarction. Our aims were to (1) analyze the early discontinuation rate of P2Y(12) antagonists post–percutaneous coronary interventi...
Autores principales: | Harris, Daniel E., Lacey, Arron, Akbari, Ashley, Obaid, Daniel R., Smith, Dave A., Jenkins, Geraint H., Barry, James P., Gravenor, Mike B., Halcox, Julian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898825/ https://www.ncbi.nlm.nih.gov/pubmed/31658860 http://dx.doi.org/10.1161/JAHA.119.012812 |
Ejemplares similares
-
Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex
por: Ellins, Elizabeth A., et al.
Publicado: (2022) -
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study
por: Ellins, Elizabeth A, et al.
Publicado: (2023) -
Identifying unmet antithrombotic therapeutic need, and implications for stroke and systemic embolism in atrial fibrillation patients: a population-scale longitudinal study
por: Torabi, Fatemeh, et al.
Publicado: (2022) -
SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S(4)-BOW-AF)
por: Harris, Daniel E, et al.
Publicado: (2023) -
Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales, UK
por: Torabi, Fatemeh, et al.
Publicado: (2022)